Skip to content

Clinical study of cimetidine combined with mild hypothermia in the treatment of neonatal hypoxic ischemic encephalopathy

Clinical study of cimetidine combined with mild hypothermia in the treatment of neonatal hypoxic ischemic encephalopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129518
Enrollment
Unknown
Registered
2026-08-05
Start date
2022-11-21
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal hypoxic ischemic encephalopathy

Interventions

Experimental group:cimetidine combined with hypothermia
Control group:Normal saline combined with mild hypothermia

Sponsors

Children’s Hospital, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The HIE group includes newborns who meet the following inclusion criteria, with a gestational age of >=36 weeks and a birth weight of >=2500 g, and who also have the following conditions: 1. Evidence of fetal distress in the uterus (including at least one of the following): (1) Acute perinatal events, such as placental abruption or umbilical cord prolapse, or severe abnormal fetal heart rate variability or delayed deceleration; (2) Cord blood pH < 7.0 or BE <= -12 mmol/L; 2. Evidence of neonatal asphyxia (including any one of the following 3 items): (1) Apgar score < 5 points within 5 minutes; (2) Cord blood or arterial blood gas analysis within 1 hour after birth: pH < 7.0 or BE <= -12 mmol/L; (3) Positive pressure ventilation is required for at least 10 minutes; 3. Signs of moderate or moderate to severe encephalopathy in newborns with HIE, such as drowsiness, seizures, abnormal reflexes, or neonatal hypotonia, or evidence of abnormal brain function monitoring using aEEG.

Exclusion criteria

Exclusion criteria: Exclusion criteria (if any of the following items are met, they are excluded): 1. Plan to remove life support immediately; 2. Craniocerebral trauma or moderate to severe intracranial hemorrhage; 3. Clinically prone to spontaneous bleeding or platelet count < 50 × 10^9/L; 4. Uncontrolled hypoxia caused by persistent pulmonary hypertension. A comprehensive neurological assessment was conducted by a researcher at the time of registration. The severity of HIE is graded based on the Sarnat assessment.

Design outcomes

Primary

MeasureTime frame
Head MRI;Head ultrasound;electroencephalogram;Bayley scales of infant development;Hearing Test;examination of visual acuity;Head circumference;

Secondary

MeasureTime frame
weight;

Countries

China

Contacts

Public ContactTianming Yuan

Children’s Hospital, Zhejiang University, School of Medicine, Hangzhou, China

yuantianming@zju.edu.cn+86 571 8667 0750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026